COVID-19: Early Vaccine Results

NEJM Journal watch

By Kelly Young

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Here are some of the latest developments on the novel coronavirus disease (COVID-19) front:

Early vaccine results: A vaccine candidate delivered via microneedle arrays has prompted an immune response to SARS-CoV-2 in rodents. The study, published in EBioMedicine, found that when mice received PittCoVax, they had an increase of antibodies within 2 weeks. Clinical trials in humans could begin in months.

EBioMedicine article on vaccine candidate (Free PDF)